Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering AG Dermatology Business “Intendis” To Begin Operations Jan. 1

This article was originally published in The Pink Sheet Daily

Executive Summary

The U.S. branch of Intendis will operate out of Montville, N.J. Leadership will include former VP of Schering AG’s U.S. dermatology business Bernhard Schefter as North America marketing head.

You may also be interested in...



Schering AG Expects Restructuring Program Will Result In Charges Of $90 Mil.

The German pharmaceutical company has cut 600 jobs out of the 2,000 that will be eliminated as part of its portfolio restructuring. Schering AG will spread the charges over 2004 and 2005.

Schering AG Expects Restructuring Program Will Result In Charges Of $90 Mil.

The German pharmaceutical company has cut 600 jobs out of the 2,000 that will be eliminated as part of its portfolio restructuring. Schering AG will spread the charges over 2004 and 2005.

Schering AG Making Oncology A Primary Focus; Dermatology Unit Will Become Separate Entity

Berlex’ German parent says the new focus will help it exploit the potential of a Phase III angiogenesis inhibitor under development with Novartis. Portfolio restructuring includes termination of R&D in cardiovascular and CNS areas, except for multiple sclerosis and Parkinson’s disease.

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel